4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Cefpodoxime: new trials by email Literature Review of Cefpodoxime trials Research Report on Cefpodoxime
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors Bevacizumab, Temozolomide, Vincristine - Solid Tumor | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 13 | 2008-10-01 | 2021-02-10 |
| Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma Irinotecan and Bortezomib - Neuroblastoma | Phase 1 | Completed | University of Michigan Rogel Cancer Center | 18 | 2008-04-01 | 2017-07-06 |
| Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors Irinotecan, Cefpodoxime - Neoplasm, Diarrhea | Phase 1 | Completed | St. Jude Children's Research Hospital | 20 | 2003-09-01 | 2017-04-26 |
| Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors Irinotecan, ZD1839, Vincristine, Cefixime, Cefpodoxime. - Solid Tumors | Phase 1 | Completed | St. Jude Children's Research Hospital | 34 | 2003-05-01 | 2017-04-26 |
Diarrhea (1) · Neoplasms (1) · Neuroblastoma (1)
St. Jude Children's Research Hospital (2) · Children's Hospital Medical Center, Cincinnati (1) · University of Michigan Rogel Cancer Center (1)
United States (4)
Brian Turpin, D.O. (1) · Carlos Rodriguez-Galindo, MD (1) · Rajen Mody, MD (1) · Wayne Furman, M.D. (1)